M&A Took A Holiday In Q3, With Decreased Volume And Value

M&A review
Q3 2024 yielded a decline in M&A volume and value for the second consecutive quarter • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business